Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Non-Current Debt: 2010-2025

Historic Non-Current Debt for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to $121.2 million.

  • Lifecore Biomedical's Non-Current Debt rose 20.21% to $121.2 million in Q2 2025 from the same period last year, while for May 2025 it was $121.2 million, marking a year-over-year increase of 20.21%. This contributed to the annual value of $121.2 million for FY2025, which is 20.21% up from last year.
  • Latest data reveals that Lifecore Biomedical reported Non-Current Debt of $121.2 million as of Q2 2025, which was up 4.79% from $115.7 million recorded in Q1 2025.
  • Lifecore Biomedical's 5-year Non-Current Debt high stood at $164.9 million for Q2 2021, and its period low was $79.6 million during Q1 2022.
  • For the 3-year period, Lifecore Biomedical's Non-Current Debt averaged around $101.3 million, with its median value being $99.9 million (2023).
  • Per our database at Business Quant, Lifecore Biomedical's Non-Current Debt skyrocketed by 62.68% in 2021 and then plummeted by 45.12% in 2022.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Non-Current Debt stood at $124.2 million in 2021, then crashed by 45.12% to $79.6 million in 2022, then climbed by 24.25% to $92.1 million in 2023, then grew by 20.03% to $110.5 million in 2024, then climbed by 20.21% to $121.2 million in 2025.
  • Its Non-Current Debt stands at $121.2 million for Q2 2025, versus $115.7 million for Q1 2025 and $110.5 million for Q4 2024.